NICE and Wegovy – so much that cannot be seen

[Part two of a review on the National Institute for Health and Care Excellence (NICE). Which approved Wegovy (semaglutide) for use in preventing CV disease]. Stripping it down to basics, the key messages from the NICE report were: You may have noticed three little black boxes. Yes, redacted, redacted, and … yes, well, redacted once [ ]